Characteristics | N (%) |
---|---|
Age | |
Median age 48 years | |
(range 16–78 year) | |
≤48 | 276(76.0%) |
>48 | 87(24.0%) |
Gender | |
Male | 285(78.5%) |
Female | 78 (21.5%) |
Histopathology(WHO) | |
Type I | 17(4.7%) |
Type II | 216(59.5%) |
Type III | 130(35.8%) |
T-classification | |
T1 | 49(13.5%) |
T2 | 116(31.9%) |
T3 | 125(34.4%) |
T4 | 73(20.2%) |
N-classification | |
N0 | 44(12.1%) |
N1 | 166(45.7%) |
N2 | 121(33.3%) |
N3 | 32(8.9%) |
Clinical stage | |
I | 16(4.4%) |
II | 94(25.9%) |
III | 165(45.4%) |
IV | 88(24.3%) |
Chemotherapy | |
YES | 270(74.4%) |
NO | 93(25.6%) |